Advertisement
Advertisement

EWTX

EWTX logo

Edgewise Therapeutics, Inc. Common Stock

22.93
USD
Sponsored
-0.64
-2.69%
Jan 06, 15:59 UTC -5
Closed
exchange

After-Market

22.94

+0.01
+0.02%

EWTX Earnings Reports

Positive Surprise Ratio

EWTX beat 13 of 19 last estimates.

68%

Next Report

Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.44
Implied change from Q3 25 (Revenue/ EPS)
--
/
+12.82%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+4.76%

Edgewise Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, EWTX reported earnings of -0.39 USD per share (EPS) for Q3 25, beating the estimate of -0.40 USD, resulting in a 3.82% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an increase of 12.82% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
Dec 23, 2025 For Q4 25
Estimate
-$0.12
Actual
-$0.06
Surprise
+50.98%
FAQ
For Q3 2025, Edgewise Therapeutics, Inc. Common Stock reported EPS of -$0.39, beating estimates by 3.82%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.61%, changed from $17.37 before the earnings release to $17.09 the day after.
The next earning report is scheduled for Mar 02, 2026.
Based on 14 analysts, Edgewise Therapeutics, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement